Grimes & Company, Inc. Alcon Inc Transaction History

Grimes & Company, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$55.23 - $62.39 $621,779 - $702,386	-11,258 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$49.45 - $64.16 $38,175 - $49,531	-772 Reduced 6.42%	11,258 $645,000
Q1 2020 May 05, 2020	SELL	$39.86 - $63.46 $5,979 - $9,519	-150 Reduced 1.23%	12,030 $611,000
Q4 2019 Feb 05, 2020	SELL	$55.04 - $59.27 $10,622 - $11,439	-193 Reduced 1.56%	12,180 $689,000
Q3 2019 Nov 05, 2019	SELL	$58.2 - $62.42 $7,216 - $7,740	-124 Reduced 0.99%	12,373 $721,000
Q2 2019 Jul 30, 2019	BUY	$54.43 - $63.33 $680,211 - $791,435	12,497 New	12,497 $775,000

729

242M

2.35M

1.65M

Ticker ALC
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 490,087,008
Market Cap $41.4B
Description
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Grimes & Company, Inc. with notifications on news.